866-997-4948(US-Canada Toll Free)

Prostate Cancer - Current and Future Players

Published By :

GlobalData

Published Date : Apr 2015

Category :

Cancer

No. of Pages : 60 Pages

Prostate Cancer - Current and Future Players

Summary

GlobalData has released its pharma report, Prostate Cancer - Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Prostate Cancer Market. The report identifies and analyses the key companies shaping and driving the global Prostate Cancer market. The report provides insight into the competitive Prostate Cancer landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalDatas team of industry experts.

*This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase.

Scope

- Investigation of current and future market competition for Prostate Cancer
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of Prostate Cancer sector through market impact analysis, future market scenario and company analysis

Reasons to buy

- Gain a high level view of the trends shaping and driving Prostate Cancer market
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- Whats the next big thing in the global Prostate Cancer market landscape? Identify, understand and capitalize
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 Catalyst 5
2.2 Related Reports 5
2.3 Upcoming Related Reports 6
3 Market Outlook 7
3.1 Global Markets 7
3.1.1 Forecast 7
3.1.2 Drivers and Barriers - Global Issues 11
4 Current and Future Players 12
4.1 Overview 12
4.2 Trends in Corporate Strategy 14
4.3 Company Profiles 15
4.3.1 Astellas 15
4.3.2 Johnson & Johnson 17
4.3.3 Bayer 19
5 Appendix 21
5.1 Bibliography 21
5.2 Abbreviations 40
5.3 Methodology 45
5.4 Forecasting Methodology 45
5.4.1 Diagnosed Prostate Cancer Patients 45
5.4.2 Percentage Drug-Treated Patients 46
5.4.3 Drugs Included in Each Therapeutic Class 46
5.4.4 Launch and Patent Expiry Dates 47
5.4.5 General Pricing Assumptions 48
5.4.6 Individual Drug Assumptions 49
5.4.7 Pricing of Pipeline Agents 52
5.5 Primary Research - KOLs Interviewed for This Report 54
5.6 Primary Research - Prescriber Survey 56
5.7 About the Authors 57
5.7.1 Analyst 57
5.7.2 Director of Oncology 57
5.7.3 Epidemiologist 58
5.7.4 Global Head of Healthcare 58
5.8 About GlobalData 59
5.9 Disclaimer 59

1.1 List of Tables
Table 1: Global Sales Forecasts ($m) for Prostate Cancer, 2013-2023 9
Table 2: Global Prostate Cancer Market - Drivers and Barriers, 2013-2023 11
Table 3: Key Companies in the Prostate Cancer Market in the 9MM, 2014 13
Table 4: Astellas Prostate Cancer Portfolio Assessment, 2014 17
Table 5: J&Js Prostate Cancer Portfolio Assessment, 2014 19
Table 6: Bayers Prostate Cancer Portfolio Assessment, 2014 20
Table 7: Key Launch Dates, Marketed and Pipeline Prostate Cancer Drugs 47
Table 8: Key Patent Expiration or Loss of Market Exclusivity Dates, Marketed Prostate Cancer Drugs 47
Table 9: Average Body Weight and Surface Area Across the 9MM 49
Table 10: High-Prescribing Physicians (Non-KOLs) Surveyed, By Country 56

1.2 List of Figures
Figure 1: Global Sales for Prostate Cancer by Region, 2013-2023 10
Figure 2: Company Portfolio Gap Analysis in Prostate Cancer, 2013-2023 14

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *